Medline Inc. (MDLN): price, analyst ratings, earnings and fundamentals
Updated 16 September 2026, 08:02 ET
Medline Inc. (MDLN) closed at $32.11 on 15 September 2026, down 1.5%. The stock is down 10.2% over one month. It trades 36.9% below its 52-week high of $50.88. Analysts recorded 10 actions in the last 90 days; the median price target of $46 is 41.7% above the last close. The company last reported on 5 August 2026 for Q2 2026: EPS of $0.50 against an estimate of $0.32, a beat of 56.2%, on revenue of $7.7 billion.
Price and performance
Performance figures use dividend and split adjusted closes over trading sessions, so a one-year move compares the last close with the close 252 sessions earlier. The 52-week range uses the adjusted daily highs and lows of the same window. Read the guide: Momentum, trend and technical indicators.
The live chart with technical indicators is in the app: open MDLN in FundSpec.
Analyst ratings
Over the last 90 days FundSpec recorded 10 analyst actions on MDLN from 9 firms: 10 maintained or reiterated a view. Price targets were 8 lowered. The most recent targets from 14 firms range from $34 to $55, with a median of $46, 41.7% above the last close.
| Date | Firm | Action | Price target |
|---|---|---|---|
| 27 Aug 2026 | BTIG | Reiterates Buy | $55.00 |
| 12 Aug 2026 | JP Morgan | Maintains Overweight | $53.00 to $46.00 |
| 11 Aug 2026 | Tigress Financial | Maintains Buy | $62.00 to $55.00 |
| 11 Aug 2026 | Wells Fargo | Maintains Equal-Weight | $45.00 to $34.00 |
| 10 Aug 2026 | TD Cowen | Maintains Buy | $53.00 to $45.00 |
| 6 Aug 2026 | RBC Capital | Maintains Outperform | $53.00 to $46.00 |
| 6 Aug 2026 | Truist Securities | Maintains Buy | $56.00 to $47.00 |
| 6 Aug 2026 | Evercore ISI Group | Maintains Outperform | $48.00 to $39.00 |
| 6 Aug 2026 | Stifel | Maintains Buy | $50.00 to $45.00 |
| 31 Jul 2026 | BTIG | Reiterates Buy | $55.00 |
A price target is one firm's twelve-month view, and the median across firms is a steadier reading than any single call. Upgrades and downgrades matter more when they change a rating, not only a target. Read the guide: What analyst ratings and price targets actually tell you.
Every action with the firm's history is in Analyst Ratings.
Earnings
The next report is scheduled for 18 February 2027 before the open for Q4 2026, with EPS expected at $0.40 on revenue of $8.5 billion. Medline Inc. beat the EPS estimate in 2 of its last 3 reported quarters.
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | 5 Aug 2026 | $0.32 | $0.50 | +56.25% | $7.7B |
| Q1 2026 | 6 May 2026 | $0.29 | $0.33 | +13.79% | $7.4B |
| Q4 2025 | 25 Feb 2026 | $0.24 | -$0.01 | -104.17% | $7.8B |
An earnings surprise is the reported EPS against the consensus estimate on the day. The price reaction depends as much on guidance and on what was already priced in as on the surprise itself. Read the guide: Earnings season: estimates, surprises and price reaction.
Estimates, confirmed dates and alerts for every company are in Earnings.
Fundamentals
On a trailing twelve month basis the company shows revenue growth of N.A., a gross margin of N.A., an operating margin of N.A. and a return on equity of N.A..
Margins and returns say how much of each dollar of sales becomes profit and how hard the balance sheet is working; leverage and liquidity say how much room the company has when conditions turn. Read the guide: A practical guide to discounted cash flow valuation.
Fair value, peer multiples and the full statement history are in the app: open MDLN in FundSpec.
SEC filings
The latest filing is a 10-Q from 5 August 2026.
| Filed | Form | Document |
|---|---|---|
| 5 Aug 2026 | 10-Q | View on sec.gov |
| 6 May 2026 | 10-Q | View on sec.gov |
| 25 Feb 2026 | 10-K | View on sec.gov |
Company profile
- Exchange
- Nasdaq
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Headquarters
- NORTHFIELD, Illinois
- Chief executive
- James M. Boyle
- Employees
- 43,000
- Website
- www.medline.com
- SEC CIK
- 0002046386
Our mission is to make healthcare run better by delivering improved clinical, financial, and operational outcomes. We are the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care, based on total net sales of med-surg products. Our principal executive offices are located in Northfield, Illinois.
Sector and peers
Medline Inc. is part of the Manufacturing sector, which FundSpec tracks across 1 company.
Companies in the same industry by market capitalization:
GEHC GE HealthCare Technologies Inc.
Put two of them side by side in Compare.
In FundSpec: the fair value estimate, the momentum reading, relative valuation against sector and industry peers, unusual options activity and AI model signals for MDLN are available to subscribers, with the same screen in the iOS and Android apps.
Open MDLN in FundSpec